We have shown previously that gene VI of cauliflower mosaic virus (CaMV) strain D4 governs systemic infection of Nicotiana bigelovii and that transgenic N. bigelovii expressing the 0 4 gene VI product can complement at least one CaMV isolate for long-distance transport. We have now found that DNA of two other isolates of CaMV recombine with the gene VI coding sequence present in the transgenic plants. The formation of recombinant viruses occurs as a consequence of CaMV replication, involving two template switches during reverse transcription of the CaMV RNA to DNA. The first template switch occurs at the 5' end of the 35s RNA to the gene VI mRNA produced by the transgenic plants. A second switch occurs at the 5' end of the gene VI mRNA back to the 35s RNA. We also demonstrate that CaMV can acquire sequences from transgenic plants that alter the symptomatology and host range of the virus, an observation that may have important risk assessment implications for strategies using pathogen-derived resistance to protect plants against virus diseases.
INTRODUCTION
The mechanisms that govern the ability of a plant to resist infection by a virus may be divided into active and passive components (Fraser, 1990; Dawson and Hilf, 1992) . Avirus may be unable to systemically infect a plant because of a passive defect in some aspect of the infection cycle, or viral proteins may trigger an active plant defense response that limits further spread. For example, the host range of many plant viruses may be limited by a passive defect in cell-to-cell movement (Atabekov and Taliansky, 1990; de Jong and Ahlquist, 1992) . In contrast, the coat protein of tobacco mosaic virus (TMV) elicits an active defense reaction, termed the hypersensitive response, in tobacco varieties that carry the N resistance gene (Culver et al., 1991) . In both cases, the viruses are unable to move systemically, but the underlying mechanisms are quite different. In some host-virus interactions it is difficult to distinguish between active or passive resistance mechanisms. For example, the 30-kD movement protein of TMV interacts with the product of the Tm-2 resistance gene in tomatoes to determine resistance or susceptibility, but it is not known whether the 30-kD protein is defective in its role for cell-to-cell movement or elicits an active defense response (Meshi et al., 1989) .
In studying the interaction of the plant pararetrovirus cauliflower mosaic virus (CaMV) with its solanaceous hosts, we have been interested in determining whether the resistance mechanisms of the Solanaceae to CaMV are active or passive. CaMV is a double-stranded DNA plant virus that replicates through reverse transcription of its DNA genome, as illustrated To whom correspondence should be addressed.
in Figure 1 (reviewed in Guilfoyle, 1987; Mason et al., 1987) . All CaMV strains infect a wide range of crucifers, but strains can be distinguished by their ability to systemically infect members of the Solanaceae. For example, the CaMV strains D4 and W260 systemically infect solanaceous species such as Nicotiana bigelovii and Datura stramonium, whereas strain CM1841 is unable to systemically infect any solanaceous host, inducing only local chlorotic lesions in N. bigeloviiand a hypersensitive response in D. stramonium.
Chimeric viruses constructed between D4 and CM1841, as shown in Figure 2 (H12), demonstrated that the CaMV gene VI product-a viral protein that trans activates the translation of other viral genes as shown for two caulimoviruses (Bonneville et al., 1989; Gowda et al., 1989; Fütterer and Hohn, 1991; Scholthof et al., 1992a )-determines systemic infection of D. stramonium and N. bigelovii (Daubert et al., 1984; Schoelz et al., 1986a) . In contrast, chimeric viruses constructed between W260 and CM1841 revealed that three regions of W260, consisting of gene VI, genes I and II, and gene IV, were required for W260 to systemically infect these two hosts ( Figure  2 ; W260C) (Qiu and Schoelz, 1992; Wintermantel et al., 1993) .
This raises an interesting question: Do D4 and W260 utilize different mechanisms to systemically infect the same solanaceous species? We consider here the possibility that both passive and active resistance mechanisms may limit the ability of CaMV to infect solanaceous species. It should be possible to distinguish between these alternatives by testing for complementation for systemic infection. Virus gene products that are defective in a given host should be complemented by forms of the protein that can function properly in that host. For (A) CaMV virions enter a plant cell, the viral DNA becomes unencapsidated, and the viral DNA is transported into the nucleus. The CaMV DNA contains up to three single-stranded discontinuities, which form as a consequence of the reverse transcription process. The arrowheads indicate the 3'end of the nucleotide sequence. The innermost circle illustrates the size of CaMV DNA in kilobases. (B) In the nucleus, the single-stranded discontinuities are covalently closed to form a minichromosome. RNA polymerase II synthesizes the 35s RNA, an RNA that contains a 180-nucleotide terminal redundancy, using the minichromosome as a template. The 3 ' end of the 35s RNA is indicated by the arrowhead. (C) The 35s RNA is transported from the nucleus to the cytoplasm, the cellular location for reverse transcription. DNA synthesis is primed by a methionine tRNA that binds to a 14-ribonucleotide sequence present approximately 600 nucleotides from the 5' end of the 35s RNA. (D (Keen and Staskawicz, 1988) . It is not possible to test for complementation between CaMV isolates for systemic infection because they will readily recombine when selection pressure is applied (Howell et al., 1981; Lebeurier et al., 1982) . Instead, we created transgenic N. bigelovii that express the D4 gene VI product. We used these plants to test the hypothesis that in the case of a passive resistance mechanism, defective viruses should be complemented by the transgenic plants, whereas viruses that elicit an active defense response would not be complemented.
We have already demonstrated that the resistance of N.
bigelovii to CaMV contains a passive component. The virus H31 (Figure 2 ), a W260-CM1841 chimeric virus that was used to identify the W260 host range determinants, was unable to systemically infect nontransformed N. bigelovii because of a defective interaction between gene VI of W260 and genes I to V of CM1841 (Qiu and Schoelz, 1992) . Transgenic N. bigelovii expressing the D4 gene VI product complemented H31 for systemic infection , showing that gene VI of D4 could function properly with genes I to V of CM1841 in trans . The interaction of H31 and N. bigelovii might be considered an example of passive resistance in which the infection cycle is blocked because of a defect in viral functions necessary for either expression or long-distance transport.
To determine whether a defect in the wild-type strain CM1841
forms the basis of its inability to spread in N. bigelovii, we compared the abilities of CM1841 and H31 to systemically infect transgenic N. bigelovii that express the D4 gene VI product.
In contrast to H31, CM1841 was not complemented by the transgenic plants for systemic infection, an indication that an active defense mechanism might limit spread of this virus. Tiansgenic plants inoculated with CM1841 did develop systemic symptoms, but the virus responsible for the systemic infection was a recombinant formed between CM1841 and the D4 transgene. A nucleotide sequence analysis of recombinant viruses indicated that the mechanism of recombination involved the incorporation of the information present in the D4 transgene mRNA into the CM1841 genome during reverse transcription. Figure 1 is patterned after Guilfoyle (1987) . (A) Regions of CaMV strains D4 and W260 that influence systemic infection of solanaceous species. The chimeric virus H12 has been described previously (Schoelz et al., 1986a) , whereas W260C is a composite map derived from chimeric viruses described in Qiu and Schoelz (1992) and Wintermantel et al. (1993 Genome composition of the chimeric viruses H31 and H86. The construction and testing of H31 has been described previously (Schoelz and Shepherd, 1988 ), whereas H86 is described in Wintermantel et al. (1993) . The innermost circle illustrates the size of CaMV DNA in kilobases. The curved arrm inside the circles indicates the location of the gene VI coding region. Each virus was inoculated to 10 plants and the appearance of systemic symptoms was noted at the indicated intervals.
RESULTS

CM1841
that expressed the D4 gene VI product. The W260 virus systemically infected both types of plants, as shown in Figure 3 , whereas CM1841 and H31 failed to systemically infect the nontransformed N. bigelovii, in agreement with previous studies (Schoelz et al., 1986a; Schoelz and Shepherd, 1988; Qiu and Schoelz, 1992 (6043) EcoRI (5646) EcoRJ (6043) 459 bp »--* 397 bp The CM1841 and H31 viruses were inoculated to transgenic W. bigelovii and the viruses recovered from systemically infected transgenic plants were designated CM1841R and H31CM, respectively. The CM1841R and H31CM viruses present in systemically infected transgenic N. bigelovii were subinoculated to turnips and viral DMAs were purified from infected turnip leaves. The EcoRI restriction patterns of CM1841R and H31CM were compared to viral DMA that had not been passaged through the transgenic plants. The D4 digest is of a plasmid clone. The DNA fragments were separated on a 15% (w/v) agarose gel and visualized by staining with ethidium bromide. The arrows indicate the EcoRI fragment polymorphism between D4 and CM1841 sequences. The 459-bp DNA fragment is indicative of CM1841 sequences within gene VI, whereas the 397-bp DNA segment is indicative of D4 sequences within gene VI.
In contrast to H31, the CM1841 viral DNA recovered from the systemically infected leaves of the transgenic plants (designated CM1841R) had a gene VI restriction enzyme map that corresponded to gene VI of D4, the source of gene VI in the transgenic plants. The EcoRI site at nucleotide position 6105 of the CM1841 sequence was absent from CM1841R ( Figure  4 ). Instead, CM1841R had an EcoRI site at nucleotide position 6043, a site characteristic of the D4 gene VI sequence present in the transgenic plants. In addition, CM1841R lacked a Bgll site at nucleotide position 6656 (data not shown), a restriction enzyme site that is present in the CM1841 sequence and absent in the D4 sequence. Four other restriction enzyme sites distributed throughout genes I to V that are characteristic of CM1841 were retained in CM1841R, suggesting that changes had occurred only within gene VI. We obtained CMl841R-type viruses in 10 attempts to recover CM1841 from systemically infected leaves of 10 transgenic plants from three separate experiments.
To ascertain the extent of the nucleotide differences between CM1841 and CM1841R within gene VI, we cloned CM1841R viral DNA into pUC18 at its unique Sail site, determined the nucleotide sequence of the gene VI coding region, and compared it to that of the CM1841 inoculum and the D4 sequence used for construction of the transgenic N. bigelovii. The gene VI nucleotide sequence of CM1841R revealed that it formed as a consequence of a recombination event that spanned nearly the entire length of gene VI, as shown in Figure 5 . The CM1841 and D4 sequences differ at 39 nucleotide sites within the 1203 bp Sacl-HgiAl DNA segment that comprises most of gene VI (Gardner et al., 1981; Daubert and Routh, 1990; Wintermantel et al., 1993) . The CM1841R sequence matched the D4 sequence at 38 of the 39 sites, from the first nucleotide polymorphism at 5838 to nucleotide 6694. The single site that differed from the D4 sequence and agreed with the CM1841 sequence was located at nucleotide position 6865. This observation suggests that the 3' recombination junction (positive (Left) A CMl841R-infected leaf.
sense strand) is located within the 171-bp DMA segment between 6694 and 6865. The 5' recombination junction could not be located because sequences in the transgenic plants and the virus upstream from the 5' end of the 19S RNA were derived from CM1841.
Recombinant Virus CM1841R Causes Milder Symptoms in Turnips Than CM1841 and Can Systemically Infect Solanaceous Hosts
The nucleotide sequence of gene VI of CM1841R suggested that this virus should differ phenotypically in two ways from the wild-type CM1841. First, CM1841R would be expected to induce milder symptoms in turnips than CM1841. This prediction is based on the observation that a previously constructed D4-CM1841 chimeric virus, which had nearly the same genetic composition as CM1841R, was virtually symptomless upon inoculation to turnips (Daubert et al., 1984) . CM1841R and CM1841 were each inoculated to five turnip plants, CaMV infections were verified by ELISA, and the intensity of symptoms was compared 4 weeks after inoculation. Turnips inoculated with CM1841 developed a distinct mosaic pattern, whereas the symptoms in the CM1841R-inoculated plants were barely visible, as shown in Figure 6 . Furthermore, CM1841 accumulated to a considerably higher level in infected leaves than did CM1841R. These differences confirm that CaMV can acquire genetic information from transgenic plants that can alter the severity of symptoms in a host that is universally susceptible to CaMV. A second phenotypic difference that could potentially distinguish CM1841 from CM1841R is the ability to systemically infect solanaceous species. Previous studies have shown that gene VI of D4 determines systemic infection of several such plants (Daubert et al., 1984; Schoelz et al., 1986a) . We inoculated CM1841R, CM1841, and D4 to nontransformed N. bigelovii, N. edwardsonii, N. glutinosa, N. benthamiana, and D. stramonium . As expected, none of the plants inoculated with CM1841 developed systemic symptoms, whereas a systemic mosaic appeared in the D4-inoculated plants 20 to 30 days after inoculation. In distinct contrast to CM1841, CM1841R was able to induce systemic symptoms in all of the solanaceous species, as shown in Table 1 , indicating that CM1841R had acquired the solanaceous host range of the D4 virus.
Recombination between CaMV and Transgenic Plants May Involve a Template Switch during Reverse Transcription
The CM1841 virus could not be used to identify the recombination junctions because the DNA sequences present in the transgenic plant that flank the Sacl-HgiAl DNA segment were derived from CM1841. In addition, the observation that the transgenic plants could complement H31, but not CM1841, for systemic infection indicated that CM1841 contained sequences that acted as a dominant negative inhibitor of systemic infection. To localize the recombination sites and to test whether gene VI of CM1841 acts as a dominant inhibitor of systemic infection, we examined the formation of recombinant viruses between transgenic N. bigelovii and the chimeric virus H86 (Figure 2 ). We demonstrated previously that H86 is unable to systemically infect nontransformed N. bigelovii under any environmental conditions (Wintermantel et al., 1993) , and in the present study, none of the nontransformed N. bigelovii ever developed systemic infections following inoculation with H86.
As with CM1841, transgenic N. bigelovii inoculated with H86 developed systemic symptoms, but the appearance was delayed relative to those induced by W260 and H31, as shown in Figure 7 . Restriction analysis of the H86 viral DNA recovered from systemically infected leaves suggested that individual plants had either complemented wild-type H86 (H86CM), as shown in Figure 8 , or that a recombinant H86 virus (H86R), shown in Figure 8 , became the predominant form. We attempted to obtain H86 from systemically infected leaves of 10 transgenic plants, and based on restriction analysis, we Each virus was inoculated to 10 plants, and the appearance of systemic symptoms was noted at the indicated intervals. recovered the wild-type H86 five times and a recombinant form of H86 five times. The observation that H86 systemic infections of transgenic plants can result from either complementation or recombination indicated that H86 contains some, but not all, of the regions responsible for the dominant inhibition Of CM1841.
Days after Inoculation
To verify that the transgenic N. bigelovii had complemented H86 for systemic infection, we recovered a putative wild-type H86 virus from the transgenic plants and cloned its DMA into pUC18. We determined the complete nucleotide sequence of the gene VI coding region of this clone, designated H86CM. The H86CM gene VI nucleotide sequence precisely agreed with the predicted H86 sequence, demonstrating that H86CM had been complemented by the D4 gene VI product in the transgenic plants and had not undergone recombination with gene VI sequences in the transgenic plants. In a subsequent host range test, H86CM failed to systemically infect nontransformed N. bigelovii, demonstrating that the virus had not sustained any mutations that could alter this aspect of its host range.
To investigate whether the other class of H86 viruses recovered from the transgenic plants had actually undergone recombination, we cloned a putative recombinant H86 viral DMA into pUC18, designated this virus H86R, and determined the nucleotide sequence of gene VI and flanking regions. In 5500 6000 6500
EcoRl (5646) EcoRl ( The CaMV sequences present in the transgenic plants are the same as given in Figure 4 . The sequence composition of H86 is based on nucleotide sequences determined previously (Gardner et al., 1981; Wintermantel et al., 1993) . The sequence composition of gene VI and flanking regions of H86R is based on nucleotide sequencing of the entire region presented. The unassigned sequences cannot be identified as D4, CM1841, or W260 sequences dueto a lack of sequence polymorphisms.
contrast to H86CM, the nucleotide sequence of H86R confirmed that this virus had undergone recombination with viral sequences present in the transgenic plants, as shown in Figure 9 . The 5' recombination junction (positive sense strand) was localized to a 110-bp DNA segment that contained the 5' end of the 19s RNA. The upstream DNA sequence, from the Xbal site to the 5' recombination junction, was derived from W260. Within this 750-bp DNA segment, the W260 sequence differs from CM1841 at 24 sites (Wintermantel et al., 1993) . The H86R sequence agreed with that of the W260 sequence at all24 sites. There was only one point within this segment, at nucleotide 5165, in which the H86R sequence differed from W260 and CM1841. The 3'recombination junction was localized to a 108-bp DNA segment that contained the 3' end of the 19s RNA. The DNA sequence of H86R from the 3'recombination junction to a Clal site was derived from W260. Within this 332-bp DNA segment, the W260 sequence differs from CM1841 at 14 sites (Wintermantel et al., 1993) , and the H86R sequence precisely matched the W260 sequence. In contrast to sequences flanking the 19s RNA, the 1851-bp DNA sequence between the recombination junctions that comprises the 19s RNA agreed with the sequence present in the transgenic N. bigelovii. Sequences from Sacl-HgiAl were derived from D4, whereas sequences from HgiAl to the recombination junction at the end of the 19s RNA were derived from CM1841. The locations of the 5'and 3'recombination junctions suggested that the mechanism of recombination involved a template switch during reverse transcription of the viral genome. A subsequent host range experiment with H86R demonstrated that it could systemically infect nontransformed N. bigelovii, proving that the sequences that it had acquired had altered the host range of this virus relative to that of H86.
To determine whether other recombinant H86 viruses had formed in a similar manner, we cloned three more putative recombinant H86 viruses recovered from independently infected transgenic plants, designated them H86R.1, H86R.2, and H86R.3, and identified the recombination junctions. The 5' recombination junction of all three viruses was indistinguishable from that of H86R, occurring within a 110-bp DNA segment that contained the 5' end of the 19s RNA. The 3' recombination junction of H86R.1 was the same as H86R, localized between nucleotides 7547 and 7655. The S'junction for H86R.2 was localized between nucleotides 7440 and 7547, whereas that of H86R.3 was between 7342 and 7436. Because the 3' end of the 19s RNA is located at nucleotide 7622, all of the recombination sites occurred within the 19s RNA or overlapped with the ends of the 19s RNA. This suggests that the mechanism of recombination most likely involved a template switch incorporating the 19s RNA produced by the transgenic plants into the viral genome during reverse transcription.
DISCUSSION
Two Mechanisms May Limit Ability of CaMV to Systemically lnfect Solanaceous Species
In this study, we used transgenic plants that express a host range determinant of CaMV to investigate whether the inability of certain CaMV isolates to systemically infect N. bigelovii results from a defect in the viral infection cycle or an active defense response. It is generally accepted that the host range of plant viruses may be limited by avirulence genes, which elicit a plant defense response (Dawson and Hilf, 1992) . We made the important assumption that avirulence would be dominant over virulence; this is a concept that is accepted for funga1 (de Wit, 1992) and bacterial (Staskawicz et al., 1984) plant pathogens and is assumed to be valid for viral pathogens. One prerequisite for this experiment was to prove that the transgenic N. bigelovii produced a functional gene VI product. We fulfilled this requirement by demonstrating that transgenic plants synthesized a sufficient amount of the D4 gene VI product to complement the CaMV chimeric virus H31 for systemic infection . In contrast to H31, the wildtype virus CM1841 was not complemented by the transgenic plants. Instead, the recombinant virus CM1841R predominated in infected transgenic plants. The contrasting results obtained with H31 and CM1841 suggest that two different mechanisms may regulate the ability of CaMV to systemically infect solanaceous species. One mechanism, characterized by viruses such as H31, may involve the inability of viral proteins to function properly in certain hosts. The second mechanism, characterized by viruses like CM1841, involves sequences that inhibit systemic infection in a dominant manner and must be removed or altered if spread is to occur.
The dominant inhibition exhibited by CM1841 is consistent with a model involving the elicitation of an active defense response, but other explanations cannot be excluded at this time. For example, CM1841 and H31 may both be defective in their ability to systemically infect N. bigelovii, but H31 may be able to replicate and spread more efficiently in the inoculated leaf. The infection level of H31 .might thus be sufficient to preclude the establishment of a putative H31 recombinant virus, and consequently H31 is complemented by the transgenic plants. In contrast, the CM1841 infection may be impaired to such an extent that the recombinant virus CM1841R predominates and excludes the spread of wild-type CM1841.
As a further step toward understanding the resistance mechanism of N. bigelovii to CM1841 infection, we have attempted to identify the CM1841 sequences responsible for the dominant inhibition of systemic infection of N. bigelovii. Severa1 lines of evidence suggested to us that gene VI of CM1841 might be the dominant inhibitor. First, an earlier study with chimeric viruses constructed between CM1841 and D4 showed that gene VI of CM1841 is responsible for the elicitation of the hypersensitive response in D. sframonium and for the inability to systemically infect N. bigelovii (Schoe1z et al., 1986a) . Second, gene VI may elicit a plant defense response because transgenic expression of the caulimovirus gene VI product in nonhosts results in severe stunting, chlorosis, and necrosis, whereas transgenic hosts may be unaffected by gene VI expression . Third, a comparison of the genome compositions of H31 and CM1841 indicated that either gene VI or the large intergenic region of CM1841 is responsible for the inability of CM1841 to be complemented by the transgenic N. bigelovii. Because the large intergenic region does not influence the ability of CM1841M1260 chimeric viruses to systemically infect N. bigelovii (Wintermantel et al., 1993) , we hypothesized that gene VI of CM1841 must be responsible for the dominant inhibition of CM1841.
We used chimeric virus H86 to test the ability of the CM1841 gene VI sequences to act as a dominant inhibitor and found that this virus is capable of both complementation by and recombination with CaMV sequences present in the transgenic plants. The detection of recombinant viruses in some transgenic plants inoculated with H86 indicates that the CM1841 sequences do inhibit systemic infection. However, the fact that H86 is complemented for systemic infection in other transgenic plants suggests that not all of the information necessary for dominant inhibition is present within the Sacl-HgiAl DNA segment that comprises most of gene VI. It may be significant to note that the H86 gene VI product is not identical to that of CM1841. A311-bp DNA segment between the HgiAl site and the gene VI stop codon of H86 is derived from W260, and within this region there are seven differences in the gene VI amino acid sequences of W260 and CM1841 (Wintermantel et al., 1993) . Although this heterogeneity does not influence the ability of W260KM1841 chimeric viruses to systemically infect nontransformed N. bigelovii, they may alter the H86 gene VI product so that it is unable to efficiently inhibit complementation by the transgenic plants. Alternatively, other regions of the viral genome that influence host specificity in conjunction with gene VI, such as genes I, II, and IV (Qiu and Schoelz, 1992) , may also contribute to the inability of CM1841 to be complemented by the transgenic plants.
The location of the recombination junctions of H86R suggest that this chimera formed from two recombination events at the RNA level as a consequence of reverse transcription. CaMV replicates by reverse transcription of the terminally redundant 35s RNA to produce double-stranded DNA (Guilley et al., 1983; Hull and Covey, 1983; Pfeiffer and Hohn, 1983) . We hypothesize the following scenario, as illustrated in Figure 10 . In the case of H86R, the first recombination event occurred during reverse transcription as a result of a template switch from the 5' end of the 35s viral RNA to the 3' end of the 19s RNA (gene VI mRNA) produced by the transgenic plants. As the viral reverse transcriptase reached the 5' end of the 19s RNA, a second template switch occurred from the 19s RNA back to the 35s RNA, resulting in incorporation of the information of the 19s RNA produced by the transgenic plants into the viral genome. The structure of the CM1841R virus recovered from the transgenic plants is also consistent with a template switch mechanism of recombination. The 19s RNA produced by the transgenic plants may be encapsidated into virions along with the genomic-length RNA. A previous study has indicated that reverse transcription occurs within virions (Marsh and Guilfoyle, 1987) .
The template-switching mechanism has been shown to be responsible for recombination between CaMV strains (Choe et al., 1985; Dixon et al., 1986; Grimsley et al., 1986; Stratford and Covey, 1989; Vaden and Melcher, 1990) , and template switching is known to occur between CaMV and transgenic plants (Gal et al., 1992) . In the latter case, a CaMV construct that lacked gene VI was agroinoculated onto transgenic oilseed rape plants that expressed the gene VI coding sequence and infectious CaMV virus was recovered from upper, noninoculated leaves of the transgenic oilseed rape plants. In contrast to our study, Gal et al. (1992) could not find any evidence for complementation, possibly because of the removal of sequences within gene VI of the virus that may be required in cis for efficient frans activation (Scholthof et al., 1992b) . A virus that lacks the cis-acting sequences might be at a competitive disadvantage against a putative recombinant virus that acquires the cis-acting sequences from the transgenic plants.
lmplications of Recombination between DoubleStranded DNA Plant Viruses and Transgenic Plants for Pathogen-Derived Resistance
One of the most important methods for controlling plant virus diseases in the near future will involve expression of virus genes in transgenic plants. The basic theory behind this method, termed pathogen-derived resistance, predicts that overexpression of plant virus genes or expression of virus genes at the wrong time in a transgenic plant may inhibit the ability of a virus to replicate and cause disease (Sanford and Johnston, 1985; Beachy et al., 1990; Scholthof et al., 1993; Wilson, 1993) . There is, however, some concern that the widespread use of transgenic plants in the field might lead to the formation of recombinant viruses that are more severe and have an altered host range relative to the wild-type viruses (de Zoeten, 1991) .
In assessing the potential impact of recombination between viruses and transgenic plants, it is important to consider such factors as the mechanism of recombination, the role that the transgene plays in determining symptomatology and host range, and the contribution of selection pressure to the establishment of recombinant viruses in transgenic plants. In our study and in that of Gal et al. (1992) , the predominant mechanism for recombination involved a template switch during reverse transcription, whereas Gal et ai. (1992) found that CaMV might also be capable of homologous recombination. It is conceivable that recombinant double-stranded DNA plant viruses (i.e., other members of the caulimovirus group and members of the badnavirus group) can be isolated with similar ease.
Our work has also shown that CaMV can acquire sequences that alter symptomatology and host range from transgenic plants that contain CaMV sequences. The recombinant virus CM1841R induced attenuated symptoms in turnips, but it is also possible that a recombinant virus could be more severe than the virus that was originally inoculated. The effect of recombination on symptomatology may be predicted to a certain extent by the construction of chimeric viruses in vitro between different viral strains. For example, the work of Anderson et al. (1992) predicts that recombination between the CaMV strain W260 and a transgenic plant that contains the CM1841 gene VI coding sequence could result in a strain of CaMV that is significantly more severe in turnips than the wild-type W260 virus. The uncertainty in predicting the effects of recombination on symptomatology would become important when an uncharacterized strain infects a transgenic plant, as might occur in the field. Similarly, we have shown that recombinant viruses can have the ability to systemically infect a wider range of hosts than the virus that initially infected the transgenic plant. Gene VI of strain D4 determines systemic infection of severa1 solanaceous hosts (Schoelz et ai., 1986a) , and in fact, the recombinant virus CM1841R had the host specificity of the D4virus. It is unlikely, though, that CM1841R would be able to infect a broader range of hosts than the 0 4 virus.
One aspect that we have not investigated concerns the role of selection pressure in allowing a recombinant virus to predominate in the transgenic plants. Although recombinant viruses were not detected in H31 infections of the transgenic plants, they might be expected to form between H31 and the D4 transgene at the same rate as in the CM1841-infected plants. The H31-derived recombinants might not be detected because they are unable to compete with the H31 virus that had already become established. There is ample evidence to suggest that one CaMV isolate will predominate in infected plants to the exclusion of other CaMV variants (Zhang and Melcher, 1989) . It may be that in the absence of selection pressure, as would occur in coat protein cross-protection and other forms of pathogen-derived resistance, the recombinant virus would not have any selective advantage over the original virus and might not be able to become established in the infected plants. Further investigation will be necessary to determine whether recombinant viruses replicate and spread to a significant leve1 in the absence of selection pressure.
METHODS
Cauliflower Mosalc Virus Strains, Chimeric Viruses, and Bansgenic Plants
The wild-type cauliflower mosaic virus (CaMV) strains CM1841, W260, and D4 have been described previously (Lung and Pirone, 1972; Gracia and Shepherd, 1985; Schoelz et al., 1986b) , and each of these viruses has been cloned in infectious form into bacterial plasmid vectors to eliminate sequence variation within the viral populations (Howarth et al., 1981; Schoelz et al., 1986b; Schoelz and Shepherd, 1988) . The infectious clones of H12, H31, and H86 chimeric viruses have been described previously (Schoelz et al., 1986a; Schoelz and Shepherd, 1988; Wintermantel et al., 1993) . The infectious clones of the CaMV strains and chimeric viruses were inoculated to turnips as described previously (Howell et al., 1980; Lebeurier et al., 1980) , and the infected turnip leaves were subsequently lyophilized and stored at 4OC to serve as inoculum for future experiments. Transgenic Nicotiana bigelovii that express a chimeric gene VI product were constructed previously . All of the transgenic plants used in this study were heterozygous for the presence of gene VI because transgenic N. bigelovii homozygous for gene VI are severely stunted and unsuitable for host range experiments (J.E. Schoelz, unpublished data). 
159-161.
Recombinant DNA Techniques
Methods for DNA ligation, plasmid transformation, and plasmid purification have been described previously (Maniatis et al., 1982) . All plasmids were propagated in fscherichia coli JMlOl (Messing, 1979) . Vira1 DNAs were purified from infected turnip leaves according to the procedure of Gardner and Shepherd (1980) . Restriction enzymes and T4 DNA ligase were purchased from Promega or New England Biolabs (Beverly, MA). To determine CaMV DNA sequences, viral DNA segments were subcloned into the plasmid vector pUC18, and the DNA was sequenced following the dideoxy chain termination method of Sanger et al. (1977) . Oligonucleotide primers for sequencing were synthesized by the DNA Core Laboratory of the University of MissouriColumbia. Enzymes and chemicals for DNA sequencing were purchased in the Sequenase Version 2.0 kit (U.S. Biochemical Corp.). The nucleotide sequences of gene VI and flanking regions from the recombinant viruses were compared to the published sequences of CM1841, D4, and W260 (Gardner et al., 1981; Daubert and Routh, 1990; Wintermantel et al., 1993) .
Analysis of Host Specificity
Virus inoculum was prepared as described by Schoelz et al. (1986a) , and solanaceous plants were inoculated 4 to 5 weeks after seeds were sown. lnoculated plants were maintained either in growth chambers set for a 10-hr day at 18 to 2OoC or in the greenhouse during the months of October through April. Symptoms were recorded daily, and the presente or absence of systemic infection was verified by ELISA (Clark and Adams, 1977), as described by Anderson et al. (1991) .
